Q&A: Fu­ji­film Diosynth’s new CEO Lars Pe­tersen talks pri­or­i­ties and plans for the CD­MO

Last week saw a change at the top for the con­tract man­u­fac­tur­er Fu­ji­film Diosynth Biotech­nolo­gies, with Lars Pe­tersen re­plac­ing Mar­tin Mee­son as pres­i­dent and CEO.

Pe­tersen has been in the man­u­fac­tur­ing busi­ness for well over 20 years, work­ing at ma­jor man­u­fac­tur­ers such as No­vo Nordisk, Genen­tech and Bio­gen. At Fu­ji­film, where Pe­tersen has been for the last four years, he most re­cent­ly served as COO of a man­u­fac­tur­ing site in Hillerød, Den­mark, and head­ed up the large-scale strate­gic busi­ness unit.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER